Alternative versus classical activation of macrophages

Pathobiology

Volumn 67, Issue 5-6, 1999, Pages 222-226

  Goerdt, Sergij ^a   Politz, Oliver ^b   Schledzewski, Kai ^b   Birk, Robert ^b   Gratchev, Alexej ^b   Guillot, Pierre ^b   Hakiy, Nahid ^b   Klemke, Claus Detlev ^b   Dippel, Edgar ^b   Kodelja, Vitam ^b   Orfanos, Constantin E ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Alternative macrophage activation associated CC chemokine 1; Antigen presenting cells, alternative activation; Dendritic cells, immature; Macrophages, alternatively activated; Tolerance, immunological; Tumor immune escape

Indexed keywords

ANTIGEN; BETA CHEMOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4;

ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0342470977     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028096     Document Type: Conference Paper

References (17)

1. Stein M, Keshav S, Harris N, Gordon S: Interleukin-4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med 1992;176:287-292.
2. Goerdt S, Walsh LJ, Murphy GF, Pober JS: Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 1991;113:1425-1437.
3. Goerdt S, Bhardwaj R, Sorg C: Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 1993;142:1409-1422.
4. Walsh LJ, Goerdt S, Pober JS. Sueki H, Murphy GF: MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab Invest 1991; 65:732-741.
5. Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, Koch AE: Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum 1994;37:221-231.
6. Djemadji-Oudjiel N, Goerdt S, Kodelja V, Schmuth M, Orfanos CE: Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res 1996;288:757-764.
7. Kodelja V, Müller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S: Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997; 197:478-493.
8. Schebesch C, Kodelja V, Müller C, Hakij N, Orfanos CE, Goerdt S: Alternatively activated macrophages do not co-stimulate, but actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T-cells in vitro. Immunology 1997;92:478-486.
9. Kodelja V, Müller C, Politz O, Hakij N, Orfanos CE, Goerdt S: Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1a with a Th2-associated expression pattern. J Immunol 1998;160:1411-1418.
10. Politz O, Kodelja V, Guillot P, Orfanos CE, Goerdt S: Pseudoexons and regulatory elements in the genomic sequence of the β-chemokine alternative macrophage activation-associated CC-chemokine (AMAC)-1. Cytokine, in press.
11. bright monocytic/macrophagic cells. J Immunol 1994;153:4915-4924.
12. Steinbrink K, Sorg C, Macher E: Low zone tolerance to contact allergens in mice: A functional role for CD8+ T helper type 2 cells. J Exp Med 1996;183:759-768.
13. Elgert KD, Alleva DG, Mullins DW: Tumor-induced immune dysfunction: The macrophage connection. J Leukoc Biol 1998;64:275-290.
14. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159: 4772-4780.
15. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppaciaro A, Ruco L, Mantovani A: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998; 28:359-369.
16. Kodelja V, Kraft S, Politz O, Hakij N, Orfanos CE, Bieber T, Goerdt S: Langerhans cells do not express alternative macrophage activation-associated CC-chemokine (AMAC)-1. Res Immunol 1998;149:633-637.
17. Goerdt S, Orfanos CE: Other functions, other genes: Alternative activation of antigen presenting cells. Immunity 1999;10:137-142.